(Q39648576)

13 September 2017

title

Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England (English)

1 reference

13 September 2017

8

1 reference

13 September 2017

Solomon DH

1

1 reference

13 September 2017

Connelly MT

2

1 reference

13 September 2017

Rosen CJ

3

1 reference

13 September 2017

Dawson-Hughes B

4

1 reference

13 September 2017

Kiel DP

5

1 reference

13 September 2017

Greenspan SL

6

1 reference

13 September 2017

Leib ES

7

1 reference

13 September 2017

Miguel AH

9

1 reference

13 September 2017

Finkelstein JS

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

14 March 2003

1 reference

Osteoporosis International

13 September 2017

published in

1 reference

13 September 2017

volume

14

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

123-129

1 reference

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Effect of bone density information on decisions about hormone replacement therapy: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Results of bone densitometry affect women's decisions about taking measures to prevent fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Provider characteristics: impact on bone density utilization at a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Risk of new vertebral fracture in the year following a fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Hormone replacement therapy: compliance and cost after screening for osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

Principles of educational outreach ('academic detailing') to improve clinical decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-002-1326-7

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

21 January 2018

1 reference

12 December 2020

Randomized trial of osteoporosis screening. Use of hormone replacement therapy and quality-of-life results.

1 reference

12 December 2020

Effect of bone density evaluation on hormone replacement therapy prescription

1 reference

12 December 2020

Management of osteoporosis: a survey of Israeli physicians' knowledge and attitudes

1 reference

12 December 2020

Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis

1 reference

12 December 2020

Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study

1 reference

12 December 2020

Secondary prevention following fractured neck of femur: a survey of orthopaedic surgeons practice

1 reference

12 December 2020

No magic bullets: a systematic review of 102 trials of interventions to improve professional practice

1 reference

12 December 2020

Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry

1 reference

12 December 2020

Investigation and treatment of osteoporosis in patients with fragility fractures.

1 reference

12 December 2020

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

12 December 2020

Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis. A randomized trial

1 reference

12 December 2020

Low bone mass in premenopausal parous women: identification and the effect of an information and bone density feedback program

1 reference

12 December 2020

10.1007/S00198-002-1326-7

Identifiers

DOI

1 reference

13 September 2017

1 reference